Free Trial
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel Free GMP Stock Alerts

Gabelli Merger Plus+ Trust (GMP) Competitors

GBX 7.30 0.00 (0.00%)
As of 10/2/2026
Compare

GMP vs. BGHS, ANII, OTV2, BIOG, and NESF

Should you buy Gabelli Merger Plus+ Trust stock or one of its competitors? Gabelli Merger Plus+ Trust's main competitors and comparable companies include Boussard & Gavaudan GBP (BGHS), abrdn New India Investment Trust (ANII), Octopus Titan VCT (OTV2), The Biotech Growth Trust (BIOG), and NextEnergy Solar Fund (NESF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Gabelli Merger Plus+ Trust compare to Boussard & Gavaudan GBP?

Boussard & Gavaudan GBP (LON:BGHS) and Gabelli Merger Plus+ Trust (LON:GMP) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Gabelli Merger Plus+ Trust has a net margin of 29.51% compared to Boussard & Gavaudan GBP's net margin of 0.00%. Gabelli Merger Plus+ Trust's return on equity of 3.86% beat Boussard & Gavaudan GBP's return on equity.

Company Net Margins Return on Equity Return on Assets
Boussard & Gavaudan GBPN/A -5.37% -3.34%
Gabelli Merger Plus+ Trust 29.51%3.86%N/A

4.3% of Gabelli Merger Plus+ Trust shares are held by institutional investors. 2.1% of Boussard & Gavaudan GBP shares are held by insiders. Comparatively, 86.7% of Gabelli Merger Plus+ Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Boussard & Gavaudan GBP's average media sentiment score of 0.00 equaled Gabelli Merger Plus+ Trust'saverage media sentiment score.

Company Overall Sentiment
Boussard & Gavaudan GBP Neutral
Gabelli Merger Plus+ Trust Neutral

Gabelli Merger Plus+ Trust has higher revenue and earnings than Boussard & Gavaudan GBP. Boussard & Gavaudan GBP is trading at a lower price-to-earnings ratio than Gabelli Merger Plus+ Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boussard & Gavaudan GBP-£12.39M0.00-£18.37M-£1.28N/A
Gabelli Merger Plus+ Trust£540.33M0.14£300.49M£0.2925.11

Boussard & Gavaudan GBP has a beta of 0.26, suggesting that its share price is 74% less volatile than the broader market. Comparatively, Gabelli Merger Plus+ Trust has a beta of 0.09854958, suggesting that its share price is 90% less volatile than the broader market.

Summary

Gabelli Merger Plus+ Trust beats Boussard & Gavaudan GBP on 9 of the 10 factors compared between the two stocks.

How does Gabelli Merger Plus+ Trust compare to abrdn New India Investment Trust?

abrdn New India Investment Trust (LON:ANII) and Gabelli Merger Plus+ Trust (LON:GMP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

In the previous week, abrdn New India Investment Trust's average media sentiment score of 1.02 beat Gabelli Merger Plus+ Trust's score of 0.00 indicating that abrdn New India Investment Trust is being referred to more favorably in the media.

Company Overall Sentiment
abrdn New India Investment Trust Positive
Gabelli Merger Plus+ Trust Neutral

abrdn New India Investment Trust has a beta of 0.269, suggesting that its share price is 73% less volatile than the broader market. Comparatively, Gabelli Merger Plus+ Trust has a beta of 0.09854958, suggesting that its share price is 90% less volatile than the broader market.

Gabelli Merger Plus+ Trust has higher revenue and earnings than abrdn New India Investment Trust. abrdn New India Investment Trust is trading at a lower price-to-earnings ratio than Gabelli Merger Plus+ Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn New India Investment Trust-£88.86M-3.31£116.72M-£184.74N/A
Gabelli Merger Plus+ Trust£540.33M0.14£300.49M£0.2925.11

Gabelli Merger Plus+ Trust has a net margin of 29.51% compared to abrdn New India Investment Trust's net margin of -2,108.76%. Gabelli Merger Plus+ Trust's return on equity of 3.86% beat abrdn New India Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
abrdn New India Investment Trust-2,108.76% -24.12% 15.37%
Gabelli Merger Plus+ Trust 29.51%3.86%N/A

23.0% of abrdn New India Investment Trust shares are owned by institutional investors. Comparatively, 4.3% of Gabelli Merger Plus+ Trust shares are owned by institutional investors. 1.1% of abrdn New India Investment Trust shares are owned by company insiders. Comparatively, 86.7% of Gabelli Merger Plus+ Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Gabelli Merger Plus+ Trust beats abrdn New India Investment Trust on 8 of the 12 factors compared between the two stocks.

How does Gabelli Merger Plus+ Trust compare to Octopus Titan VCT?

Octopus Titan VCT (LON:OTV2) and Gabelli Merger Plus+ Trust (LON:GMP) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

In the previous week, Octopus Titan VCT had 2 more articles in the media than Gabelli Merger Plus+ Trust. MarketBeat recorded 2 mentions for Octopus Titan VCT and 0 mentions for Gabelli Merger Plus+ Trust. Octopus Titan VCT's average media sentiment score of 0.00 equaled Gabelli Merger Plus+ Trust'saverage media sentiment score.

Company Overall Sentiment
Octopus Titan VCT Neutral
Gabelli Merger Plus+ Trust Neutral

Octopus Titan VCT has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market. Comparatively, Gabelli Merger Plus+ Trust has a beta of 0.09854958, suggesting that its share price is 90% less volatile than the broader market.

Octopus Titan VCT has a net margin of 1,036.42% compared to Gabelli Merger Plus+ Trust's net margin of 29.51%. Gabelli Merger Plus+ Trust's return on equity of 3.86% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Octopus Titan VCT1,036.42% -9.60% -14.38%
Gabelli Merger Plus+ Trust 29.51%3.86%N/A

Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 2.3%. Gabelli Merger Plus+ Trust pays an annual dividend of GBX 0.48 per share and has a dividend yield of 6.6%. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. Gabelli Merger Plus+ Trust pays out 165.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Gabelli Merger Plus+ Trust has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Gabelli Merger Plus+ Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Octopus Titan VCT-£86.81M-4.18-£173.99M-£5.50N/A
Gabelli Merger Plus+ Trust£540.33M0.14£300.49M£0.2925.11

0.1% of Octopus Titan VCT shares are held by institutional investors. Comparatively, 4.3% of Gabelli Merger Plus+ Trust shares are held by institutional investors. 0.0% of Octopus Titan VCT shares are held by insiders. Comparatively, 86.7% of Gabelli Merger Plus+ Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Gabelli Merger Plus+ Trust beats Octopus Titan VCT on 11 of the 14 factors compared between the two stocks.

How does Gabelli Merger Plus+ Trust compare to The Biotech Growth Trust?

The Biotech Growth Trust (LON:BIOG) and Gabelli Merger Plus+ Trust (LON:GMP) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

In the previous week, The Biotech Growth Trust's average media sentiment score of 1.53 beat Gabelli Merger Plus+ Trust's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.

Company Overall Sentiment
The Biotech Growth Trust Very Positive
Gabelli Merger Plus+ Trust Neutral

The Biotech Growth Trust has a beta of 0.577, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, Gabelli Merger Plus+ Trust has a beta of 0.09854958, suggesting that its stock price is 90% less volatile than the broader market.

10.5% of The Biotech Growth Trust shares are held by institutional investors. Comparatively, 4.3% of Gabelli Merger Plus+ Trust shares are held by institutional investors. 1.5% of The Biotech Growth Trust shares are held by insiders. Comparatively, 86.7% of Gabelli Merger Plus+ Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

The Biotech Growth Trust has a net margin of 96.47% compared to Gabelli Merger Plus+ Trust's net margin of 29.51%. The Biotech Growth Trust's return on equity of 48.26% beat Gabelli Merger Plus+ Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
The Biotech Growth Trust96.47% 48.26% 12.39%
Gabelli Merger Plus+ Trust 29.51%3.86%N/A

Gabelli Merger Plus+ Trust has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Gabelli Merger Plus+ Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Biotech Growth Trust£133.86M2.10£83.83M£558.002.66
Gabelli Merger Plus+ Trust£540.33M0.14£300.49M£0.2925.11

Summary

The Biotech Growth Trust beats Gabelli Merger Plus+ Trust on 8 of the 12 factors compared between the two stocks.

How does Gabelli Merger Plus+ Trust compare to NextEnergy Solar Fund?

Gabelli Merger Plus+ Trust (LON:GMP) and NextEnergy Solar Fund (LON:NESF) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Gabelli Merger Plus+ Trust has a beta of 0.09854958, indicating that its stock price is 90% less volatile than the broader market. Comparatively, NextEnergy Solar Fund has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market.

In the previous week, NextEnergy Solar Fund had 1 more articles in the media than Gabelli Merger Plus+ Trust. MarketBeat recorded 1 mentions for NextEnergy Solar Fund and 0 mentions for Gabelli Merger Plus+ Trust. Gabelli Merger Plus+ Trust's average media sentiment score of 0.00 equaled NextEnergy Solar Fund'saverage media sentiment score.

Company Overall Sentiment
Gabelli Merger Plus+ Trust Neutral
NextEnergy Solar Fund Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gabelli Merger Plus+ Trust
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NextEnergy Solar Fund
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Gabelli Merger Plus+ Trust pays an annual dividend of GBX 0.48 per share and has a dividend yield of 6.6%. NextEnergy Solar Fund pays an annual dividend of GBX 8.43 per share and has a dividend yield of 17.4%. Gabelli Merger Plus+ Trust pays out 165.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NextEnergy Solar Fund pays out -79.5% of its earnings in the form of a dividend. NextEnergy Solar Fund is clearly the better dividend stock, given its higher yield and lower payout ratio.

Gabelli Merger Plus+ Trust has a net margin of 29.51% compared to NextEnergy Solar Fund's net margin of -183.46%. Gabelli Merger Plus+ Trust's return on equity of 3.86% beat NextEnergy Solar Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Gabelli Merger Plus+ Trust29.51% 3.86% N/A
NextEnergy Solar Fund -183.46%-12.87%-2.16%

4.3% of Gabelli Merger Plus+ Trust shares are owned by institutional investors. Comparatively, 25.9% of NextEnergy Solar Fund shares are owned by institutional investors. 86.7% of Gabelli Merger Plus+ Trust shares are owned by insiders. Comparatively, 0.1% of NextEnergy Solar Fund shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Gabelli Merger Plus+ Trust has higher revenue and earnings than NextEnergy Solar Fund. NextEnergy Solar Fund is trading at a lower price-to-earnings ratio than Gabelli Merger Plus+ Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gabelli Merger Plus+ Trust£540.33M0.14£300.49M£0.2925.11
NextEnergy Solar Fund-£48.91M-5.71-£13.68M-£10.61N/A

Summary

Gabelli Merger Plus+ Trust beats NextEnergy Solar Fund on 9 of the 15 factors compared between the two stocks.

Get Gabelli Merger Plus+ Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMP vs. The Competition

Export
MetricGabelli Merger Plus+ TrustCapital Markets IndustryFinance SectorLON Exchange
Market Cap£75.44M£5.16B£13.12B£2.46B
Dividend Yield6.50%7.57%6.04%6.25%
P/E Ratio25.1129.4524.42366.74
Price / Sales0.141,200.87500.0889,426.67
Price / CashN/A47.6745.5127.89
Price / Book0.013.482.706.83
Net Income£300.49M£416.56M£1.32B£5.89B
7 Day PerformanceN/A-0.74%-1.04%-0.72%
1 Month PerformanceN/A-2.71%-3.20%-1.01%
1 Year PerformanceN/A9.00%10.47%22.82%

Gabelli Merger Plus+ Trust Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMP
Gabelli Merger Plus+ Trust
N/AGBX 7.30
flat		N/AN/A£75.44M£540.33M25.11N/A
BGHS
Boussard & Gavaudan GBP
N/AN/AN/AN/A£300.90M-£12.39MN/AN/A
ANII
abrdn New India Investment Trust
N/AGBX 702
-2.0%		N/A-10.2%£299.59M-£88.86MN/AN/A
OTV2
Octopus Titan VCT
N/AGBX 18
flat		N/A+22.2%£296.68M-£86.81MN/A30
BIOG
The Biotech Growth Trust
N/AGBX 1,538
-0.6%		N/A+44.6%£292.01M£133.86M2.76N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:GMP) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...
Stansberry Research | Sponsoredtc pixel
Elon Warns "America Will Go Bankrupt". Trump's Plan Inside.
National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...
American Hartford Gold | Sponsoredtc pixel
WATCH THIS BEFORE DECEMBER 8th!!
James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...
Paradigm Press | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...
Banyan Hill Publishing | Sponsoredtc pixel
I'm giving you a space stock today. Free.
On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...
Behind the Markets | Sponsoredtc pixel
How Elon’s Empire Ends (and how to profit)
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...
Chaikin Analytics | Sponsoredtc pixel